eMedicine Specialties > Pediatrics: General Medicine > Allergy & Immunology
Allergic Rhinitis
Updated: Jul 13, 2009
Introduction
Background
Although allergic rhinitis (AR) is a common disease, the impact on daily life cannot be underestimated. Some patients find allergic rhinitis to be just as debilitating and intrusive as severe asthma. Employees with untreated allergies are reportedly 10% less productive than coworkers without allergies, whereas those using allergy medications to treat allergic rhinitis were only 3% less productive.1 This suggests that effective medications may reduce the overall cost of decreased productivity.
Allergic rhinitis is caused by an immunoglobulin E (IgE)–mediated reaction to various allergens in the nasal mucosa. The most common allergens include dust mites, pet danders, cockroaches, molds, and pollens. For example, tree pollen allergen binds to IgE antibodies that are attached to a mast cell via Fce receptor. When 2 IgE molecules bind to the same tree pollen allergen, they cause the mast cell to fire off (degranurate), leading to release of various inflammatory mediators that cause the symptoms we feel as allergic rhinitis, including sneezing; nasal congestion; stuffiness; rhinorrhea (runny nose); cough; itching of the nose, eyes, and throat; sinus pressure; headache; and epistaxis (bloody nose).
The allergens present in the outdoor environment vary with the time of year and location. Knowing what allergens are in the environment at a specific time of year helps in diagnosing and treating allergic rhinitis and helps in excluding allergy as a cause of the patient's symptoms. For example, a patient who presents with nasal congestion in November in Boston, Massachusetts cannot have allergic rhinitis attributed to tree pollen allergy, which is prevalent in spring.
Allergen exposure likely causes both upper and lower airway inflammation, meaning that both the nose and the lungs may be involved. Many experts believe that a patient's airway needs to be evaluated as a total entity, not as individual parts. Studies have shown that most patients with asthma also have allergic rhinitis. Guidelines regarding the impact of allergic rhinitis on asthma have been established.2 Allergic reactions of the upper airway can trigger lower airway symptoms and vice versa. One study showed that patients with untreated allergic rhinitis and asthma have an almost 2-fold greater risk of having an emergency department visit and almost a 3-fold greater risk of being hospitalized for an asthma exacerbation, respectively.3 Similarly there are studies that reveal treatment of one disease entity improves the other.
See Media files 3-5 for graphs that detail the significant impact of nasal allergies.
Pathophysiology
Understanding the function of the nose is important in order to understand allergic rhinitis. The purpose of the nose is to filter, humidify, and regulate the temperature of inspired air. This is accomplished on a large surface area spread over 3 turbinates in each nostril. A triad of physical elements (ie, a thin layer of mucus, cilia, and vibrissae [hairs] that trap particles in the air) accomplishes temperature regulation. The amount of blood flow to each nostril regulates the size of the turbinates and affects airflow resistance. The nature of the filtered particles can affect the nose. Irritants (eg, cigarette smoke, cold air) cause short-term rhinitis; however, allergens cause a cascade of events that can lead to more significant inflammatory reactions.
In short, rhinitis results from a local defense mechanism in the nasal airways that attempts to prevent irritants and allergens from entering the lungs.
Allergic reactions require exposure and then sensitization to allergens. To be sensitized, the patient must be exposed to allergens for a period of time. Sensitization to highly allergenic indoor allergens can occur in children younger than 2 years. Sensitization to outdoor allergens usually occurs when a child is older than 3-5 years, and the average age at presentation is 9-10 years. The allergic reaction begins with the cross-linking of the allergen to 2 adjacent IgE molecules that are bound to high-affinity Fcε receptors on the surface of a mast cell. This cross-linking causes mast cells to degranulate, releasing various mediators. The best-known mediators are histamine, prostaglandin D2, tryptase, heparin, and platelet-activating factor, as well as leukotrienes and other cytokines.
These substances produce 2 types of reactions: immediate and late-phase. The immediate reactions in the nasal mucosa induce acute allergy symptoms (eg, nasal itch, clear nasal discharge, sneezing, congestion). The late-phase reaction occurs hours later, secondary to the recruitment of inflammatory cells into the tissue by the action of mediators (termed chemokines) released by the mast cell. Recruited cells are predominated by eosinophils and basophils, which, in turn, release their inflammatory mediators, leading to continuation of the cascade. In very sensitive individuals, this allergen-induced nasal inflammation causes priming of the nasal mucosa. Primed nasal mucosa becomes hyperresponsive, at which point even nonspecific triggers or small amounts of the antigen can cause significant symptoms.
Frequency
United States
Prevalence in the United States is 10-20%.4 One survey demonstrated rates as high as 38.2% when patients were asked if they experienced fewer than 7 days of symptoms. When allergic rhinitis was defined as symptoms lasting more than 31 days, prevalence dropped to 17%.
International
In temperate areas of Europe and Asia, frequency is similar to that in the United States.
Mortality/Morbidity
Mortality is not associated with allergic rhinitis, but significant morbidity occurs. Morbidity is manifested in several ways. Annually, an estimated 824,000 school days are missed, and an estimated 4,230,000 days of reduced quality-of-life functions are reported.5 Comorbidity of other atopic diseases (asthma, atopic dermatitis) or upper airway inflammation (sinusitis, otitis media) is significant in allergic rhinitis. Individuals with allergic rhinitis have a higher frequency of these conditions than individuals without allergic rhinitis.
Quality-of-life surveys have revealed that patients with significant allergic rhinitis found symptoms to be just as debilitating as symptoms in patients with moderate-to-severe asthma. Patients with allergic rhinitis felt they were equally impaired and unable to participate in the activities of normal living similar to those with the moderate-to-severe asthma. They felt that chronic congestion, sneezing, the need to wipe the nose, and a decrease in restful sleep compromised levels of their daily activity.
The financial cost of allergic rhinitis is difficult to estimate. Self-treating patients are estimated to spend an average of 56 dollars per year. The direct cost of prescription medication exceeds 6 billion dollars per year worldwide, and lost productivity is estimated at 1.5 billion dollars per year.
Race
Allergic rhinitis has no race predilection; however, individuals from nonwhite backgrounds seek out medical attention less often than whites.
Sex
Allergic rhinitis has no sex predilection.
Age
Allergic rhinitis usually presents in early childhood. Allergic rhinitis caused by sensitization to outdoor allergens can occur in children older than 2 years; however, sensitization in children aged 4-6 years is more common. Clinically significant sensitization to indoor allergens may occur in children younger than 2 years. This is typically associated with significant exposures to indoor allergens (eg, molds, furry animals, cockroaches, dust mites). Some children may be sensitized to outdoor allergens at this young age if they have significant exposure. Incidence continues to increase until the fourth decade of life, when symptoms begin to fade; however, individuals can develop symptoms at any age.
Clinical
History
The history of the patient with allergic rhinitis (AR) may be straightforward or may include a complex set of symptoms. The diagnosis is easy to make in a patient with a new pet or with symptoms that have distinct seasonal variation. Alternatively, younger patients may present with varying signs or symptoms, the family may not appreciate the nasal stuffiness but may note the chronic nasal congestion. In older children, symptoms may have been present for years and, therefore, appear to be less severe because the child has accommodated them.
Physicians should try to identify seasonal variations, provocative elements in the environment, and the timing of events that lead to symptoms. Few patients present soon after the onset of allergic rhinitis symptoms. Usually, allergic rhinitis symptoms have been present for years and have been slowly worsening during each allergy season.
This is especially true for patients with pet allergies. The symptoms appear slowly, over years. They can worsen in the spring and fall and be confused with pollen allergy. This occurs for pets usually shed more in the warmer weather and then in the fall when more time is spent indoors with worsening symptoms. Also, many families believe that the fact that the pet was present before the onset of the child's symptoms exclude the possibility of allergy to the family pet, but this is not true. The family often believe that the family pet is hypoallergenic. No cats or dogs are truly hypoallergenic.
Unless a new exposure to large amounts of allergens is reported (eg, pet, feather pillow), a patient who describes a sudden onset of nasal allergy symptoms is not experiencing allergic symptoms. Sudden onset of nasal symptoms is often associated with acute sinusitis or acute bacterial sinusitis superimposed on chronic sinusitis. In children younger than 5 years, differentiating allergy symptoms from recurrent upper respiratory viral infection is even more difficult, especially in those who attend daycare and experience frequent rhinitis symptoms.
- Nature of symptoms
- Symptoms of rhinitis consist of rhinorrhea, nasal congestion, postnasal drainage, repetitive sneezing, and itching of the palate, nose, or eyes. Snoring, frequent sore throats, constant clearing of the throat, cough, itchy eyes, and headaches are symptoms often associated with rhinitis.
- When obtaining the history, ascertain the following:
- Determine which symptoms are reported by the patient or parent.
- Determine whether the patient has rhinorrhea, sniffling, nasal itching, sneezing, cough, congestion, or nasal discharge. Determine the color of the nasal discharge.
- Determine whether any associated ocular or respiratory symptoms are present.
- Ask about snoring, which may worsen in pollen season.
- Timing of symptoms
- Identify whether symptoms are present or worsen during certain seasons, such as the spring or fall. In addition, try to identify whether symptoms are worse in specific places, such as home, work, or school, or when the patient is around animals.
- Determine when symptoms occur and whether they occur primarily at night, in school, outdoors, or at a relative's or friend's home.
- Determine whether symptoms occur only at a certain time of the year or throughout the year. Remember that symptoms in the fall and spring may still indicate a pet allergy.
- Determine whether symptoms ever improve and, if so, what actions help alleviate symptoms. Most patients have tried over-the-counter antihistamine medication. If these medications help, allergic rhinitis should be suspected; however, a negative response does not eliminate the possibility of allergic rhinitis. Ask if the patient's symptoms improve when they are away from certain locations. For example, a child who has less symptoms at college or camp may have an allergy to the family pet, feather pillows, or dust mites in their bedding.
- Determine whether symptoms improve when the patient is taking antibiotics. Most patients receive antibiotics for various reasons unrelated to nasal symptoms. If symptoms respond to antibiotic therapy, the clinical diagnosis may be sinusitis, which may have been either primary sinusitis or secondary sinusitis caused by allergic rhinitis.
- Duration of symptoms
- Determine whether symptoms last for weeks, months, or hours.
- Most pollen seasons are at least 6 weeks long in more moderate climates. In the south and far north, the season can be longer or shorter, respectively. Symptoms that last less than 2 weeks rarely indicate allergic rhinitis unless concomitant exposure occurs.
- In winter in the northern regions, virtually all pollens are absent; therefore, any allergic rhinitis–like symptoms are the result of indoor allergen exposure or are associated with nonallergic causes. Although patients are usually exposed to the same allergens throughout the year, allergic rhinitis symptoms triggered by indoor allergens can worsen in winter secondary to longer hours spent indoors during the cold months. This may also be associated with closed windows and doors in winter, resulting in increased recirculation of indoor allergens. An example of winter-only exposure is a person who is allergic to dust mites who uses a down comforter only during the winter (dust mites are highly infested in a down comforter.)
- Family history
- Children with parents who have allergies or asthma are more likely to be affected.
- If a child has one parent with allergies, chances are 30% that a child will have allergic rhinitis. This increases to 50-70% if both parents have allergies or atopic asthma.
- Related medical history
- Patients with a history of infantile eczema (atopic dermatitis) have a 70% chance of having allergic rhinitis, asthma, or both.
- Patients with a history of asthma also have higher incidence of allergic rhinitis.
- Social and environmental history
- The patient's environment is very important. Ask about the presence of a pet or beddings (eg, pillow, bedspread, comforter [especially containing feathers]) and other home items likely infested by dust mites (eg, carpeted floor, stuffed animals, dusty closet, nonleather furniture) as well as the timing of initial exposure. Many times, exposure to dust, feathers, or pets coincides with the onset of symptoms, making diagnosis and treatment easier. However, patients could become sensitized to indoor allergens by exposure in places other than the home where they spend a fair numbers of hours (eg, schools, daycare center, baby sitters' and relatives' homes).
- Questions must be raised regarding any environment in which the patient spends more than a few hours per week. This includes baby-sitters' and relatives' homes, daycare facilities, and schools (classroom pets).
- For children younger than 3 years, ask about the child's bed. Cribs or toddler beds that use crib mattresses do not have dust mites because of the plastic covers, but standard bedding (bed mattress) can harbor dust mites.
Physical
A full examination should always be performed to detect other diseases, such as asthma, eczema, and cystic fibrosis, which occur in connection with allergic rhinitis. Evaluation involves the head, eyes, ears, nose, and throat. Upon inspection, the following signs can be noted:
- Head
- Allergic shiners (dark, puffy, lower eyelids) may be present.
- Morgan-Dennie lines (lines under the lower eyelid) may be observed.
- Transverse crease at the lower third of the nose secondary to the allergic salute, which is the upward rubbing of the nose, is commonly seen in parents as well.
- Allergic shiners (dark, puffy, lower eyelids) may be present.
- Eyes
- Marked erythema of palpebral conjunctivae and papillary hypertrophy of tarsal conjunctivae are observed. Chemosis of the conjunctivae may be present. Patients usually have a watery discharge.
- Cataracts have occurred from severe rubbing secondary to itching.
- Ears
- Tympanic membranes should be examined for the presence of chronic infection or middle ear effusion.
- The role of allergic rhinitis in chronic otitis media is not clear, but decreased numbers of infections have been noted in children with allergic rhinitis once therapy was instituted.
- Nose
- Nasal examination is often helpful in the diagnosis.
- Turbinates are enlarged and have a pale-bluish mucosa due to edema.
- Discharge is usually clear but can be white. The discharge is rarely yellow or green. If colored discharge is observed, a diagnosis of viral infection or sinusitis should be considered.
- Dried blood is commonly observed secondary to trauma from rubbing the nose.
- Polyps are rarely observed in children. If polyps are noted or suspected, perform rhinoscopy. If polyps are detected, a workup for cystic fibrosis is mandatory in children. Also consider the diagnosis of aspirin sensitivity in adults.
- Throat
- Inspection of the dentition can be informative. Discoloration of frontal incisors and a high arched palate are associated with chronic mouth breathing. Malocclusion is commonly associated with chronic mouth breathing.
- Cobblestoning in the posterior pharynx is also a sign of follicular hypertrophy of mucosal lymphoid tissue secondary to chronic nasal congestion and postnasal drainage.
- Note the size of tonsillar tissue, which may provide a clue to the size of the adenoids; large adenoids can mimic the signs and symptoms of allergic rhinitis. Chronic nasal congestion due to adenoid hypertrophy is frequently seen in young children with recurrent otitis media and sinusitis.
Causes
- Perennial symptoms are usually caused by indoor allergens, including the following:
- Dust mites
- Cat dander
- Dog dander
- Indoor molds
- Cockroaches
- Feathers: In most occasions, feather pillows and comforters are highly allergenic, secondary to dust mite infestation. Nonfeathered bedding usually has less dust mite infestation but does have progressively more dust mites over time; dust mites lay eggs every 3 weeks and accumulate where human dander accumulates. Thus nonwashable beddings (eg, pillows, bed mattress) should be encased by dust mite–proof encasings.
- Other furry animals
- Seasonal symptoms are usually caused by airborne pollen and outdoor molds, including the following:
- Tree pollen
- Grass pollen
- Outdoor mold spores
- Weed pollen: Flowers do not cause allergic rhinitis because they do not use wind-borne pollination.
More on Allergic Rhinitis |
Overview: Allergic Rhinitis |
| Differential Diagnoses & Workup: Allergic Rhinitis |
| Treatment & Medication: Allergic Rhinitis |
| Follow-up: Allergic Rhinitis |
| Multimedia: Allergic Rhinitis |
| References |
| Next Page » |
References
Meltzer EO. Productivity costs of antihistamines in the workplace. Occup Health Saf. Aug 1996;65(8):46-50. [Medline].
[Guideline] World Health Organization (WHO). Allergic rhinitis and its impact on asthma. 2008;[Full Text].
Crystal-Peters J, Neslusan C, Crown WH, Torres A. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol. Jan 2002;109(1):57-62. [Medline].
Gendo K, Larson EB. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med. Feb 17 2004;140(4):278-89. [Medline].
Malone DC, Lawson KA, Smith DH, Arrighi HM, Battista C. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol. Jan 1997;99(1 Pt 1):22-7. [Medline].
[Best Evidence] Compalati E, Penagos M, Tarantini F, Passalacqua G, Canonica GW. Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses. Ann Allergy Asthma Immunol. Jan 2009;102(1):22-8. [Medline].
Cox LS, Larenas Linnemann D, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol. May 2006;117(5):1021-35. [Medline].
[Best Evidence] Wahn U, Tabar A, Kuna P, et al. Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis. J Allergy Clin Immunol. Jan 2009;123(1):160-166.e3. [Medline].
Aaronson DW. Side effects of rhinitis medications. J Allergy Clin Immunol. Feb 1998;101(2 Pt 2):S379-82. [Medline].
Allergies in America. Allergies in America Executive Summary. myallergiesinamerica. Available at http://www.myallergiesinamerica.com/pdfs/myaia.pdf. Accessed June 2007.
Busse W. Allergic rhinitis: charting a course for the 21st century. J Respir Dis. 1998;19:S1-64.
Day J. Pros and cons of the use of antihistamines in managing allergic rhinitis. J Allergy Clin Immunol. Mar 1999;103(3 Pt 2):S395-9. [Medline].
Day JH, Briscoe M, Widlitz MD. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. J Allergy Clin Immunol. May 1998;101(5):638-45. [Medline].
Delafuente JC, Davis TA, Davis JA. Pharmacotherapy of allergic rhinitis. Clin Pharm. Jul 1989;8(7):474-85. [Medline].
Hemp P. Presenteeism: at work--but out of it. Harv Bus Rev. Oct 2004;82(10):49-58, 155. [Medline].
Hussain I, Kline JN. DNA, the immune system, and atopic disease. J Investig Dermatol Symp Proc. Jan 2004;9(1):23-8. [Medline].
LaForce C. Use of nasal steroids in managing allergic rhinitis. J Allergy Clin Immunol. Mar 1999;103(3 Pt 2):S388-94. [Medline].
[Best Evidence] Lange B, Lukat KF, Rettig K, Holtappels G, Bachert C. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. Sep 2005;95(3):272-82. [Medline].
Ledford DK, Lockey RF. Allergic rhinitis: understanding the process. J Respir Dis. 1998;19(7):576-84.
Middleton E, Reed C, Ellis E. Allergic and non-allergic rhinitis. In: Allergy: Principles and Practice. Vol 2. 5th ed. Mosby-Year Book; 1998:Chapter 70.
Naclerio R, Solomon W. Rhinitis and inhalant allergens. JAMA. Dec 10 1997;278(22):1842-8. [Medline].
Plevkova J, Brozmanova M, Pecova R, Tatar M. Effects of intranasal histamine on the cough reflex in subjects with allergic rhinitis. J Physiol Pharmacol. Sep 2005;56 Suppl 4:185-95. [Medline].
Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc. Jan-Feb 1994;15(1):21-5. [Medline].
Spector S. Pathophysiology and pharmacotherapy of allergic rhinitis. Foreword. J Allergy Clin Immunol. Mar 1999;103(3 Pt 2):S377. [Medline].
Sublett JL. The environment and risk factors for atopy. Curr Allergy Asthma Rep. Nov 2005;5(6):445-50. [Medline].
Wheeler PW, Wheeler SF. Vasomotor rhinitis. Am Fam Physician. Sep 15 2005;72(6):1057-62. [Medline].
Further Reading
Keywords
allergic rhinitis, AR, hay fever, rose fever, spring cold, sneezing, nasal congestion, stuffiness, rhinorrhea, coughing, nasal itch, itchy eyes, scratchy throat, sinus pressure, sinus headache, epistaxis, asthma, sinusitis, atopic dermatitis, otitis media, allergen, allergy, histamine, prostaglandin D2, heparin, platelet-activating factor, cystic fibrosis, dust mites, cat dander, dog dander, indoor molds, cockroaches, tree pollen, grass pollen, weed pollen, allergens, nasal allergies, cigarette smoke, atopic dermatitis, sinusitis, upper respiratory illness, pet allergies, allergic shiners, treatment, diagnosis








Overview: Allergic Rhinitis